A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Active, not recruiting · NCT03105102 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Active, not recruiting | Phase 3 | 2026-08-14 | NCT03105102 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
496 results · Page 1 of 20
Research sites
Swipe the table sideways for more columns.